Basic Information
| RNALocate ID: | RLID-D:11000733 |
| RNA Symbol: | hsa-miR-760 |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-760 |
| RNA ID: | miRBase:MIMAT0004957 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002712 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002713 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11004176 | Exosome | Saliva | 19627513 |
| RLID:11004177 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11004178 | Exosome | Plasma | 23663360 |
| RLID:11004179 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000222 | Exosome | Blood |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-760 | Uterine corpus endometrial carcinoma | MNDR-E-MI-68883 |
| MNDR | hsa-miR-760 | Lymphoma | MNDR-E-MI-68884 |
| MNDR | hsa-miR-760 | Estrogen-receptor positive breast cancer | MNDR-E-MI-68885 |
| MNDR | hsa-miR-760 | Estrogen-receptor negative breast cancer | MNDR-E-MI-68886 |
| MNDR | hsa-miR-760 | Progesterone-receptor positive breast cancer | MNDR-E-MI-68887 |
| MNDR | hsa-miR-760 | Progesterone-receptor negative breast cancer | MNDR-E-MI-68888 |
| MNDR | hsa-miR-760 | Her2-receptor positive breast cancer | MNDR-E-MI-68889 |
| MNDR | hsa-miR-760 | Breast cancer luminal | MNDR-E-MI-68890 |
| MNDR | hsa-mir-760 | Colorectal carcinoma | MNDR-E-MI-68891 |
| MNDR | hsa-miR-760 | Prostate cancer | MNDR-E-MI-68892 |
| MNDR | hsa-miR-760 | Gastric cancer | MNDR-E-MI-68893 |
| MNDR | hsa-mir-760 | Gastric neoplasms | MNDR-E-MI-68894 |
| MNDR | hsa-miR-760 | Alzheimer disease | MNDR-E-MI-68895 |
| MNDR | hsa-miR-760 | Intracranial aneurysm | MNDR-E-MI-68896 |
| MNDR | hsa-miR-760 | Leukemia | MNDR-E-MI-68897 |
| MNDR | hsa-miR-760 | Huntington disease | MNDR-E-MI-68898 |
| MNDR | hsa-miR-760 | Chorea | MNDR-E-MI-68899 |
| MNDR | hsa-miR-760 | Lung cancer | MNDR-E-MI-68900 |
| MNDR | hsa-mir-760 | Parkinson disease | MNDR-E-MI-68901 |
| MNDR | hsa-miR-760 | Parkinson disease | MNDR-E-MI-68902 |
| MNDR | hsa-miR-760 | Breast cancer | MNDR-E-MI-68903 |
| MNDR | hsa-mir-760 | Breast neoplasms | MNDR-E-MI-68904 |
| MNDR | hsa-mir-760 | Cancer | MNDR-E-MI-68905 |
| MNDR | hsa-miR-760 | Pancreatic cancer | MNDR-E-MI-68906 |
| MNDR | hsa-miR-760 | Melanoma | MNDR-E-MI-68907 |
| MNDR | hsa-miR-760 | Rectum adenocarcinoma | MNDR-E-MI-68908 |
| MNDR | hsa-miR-760 | Colon adenocarcinoma | MNDR-E-MI-68909 |
| MNDR | hsa-miR-760 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-68910 |
| MNDR | hsa-mir-760 | Ovarian cancer | MNDR-E-MI-68911 |
| MNDR | hsa-miR-760 | Carcinoma ductal breast | MNDR-E-MI-68912 |
| MNDR | hsa-miR-760 | Glioblastoma | MNDR-E-MI-68913 |
| MNDR | hsa-miR-760 | Malignant glioma | MNDR-E-MI-68914 |
| MNDR | hsa-miR-760 | Chordoma | MNDR-E-MI-68915 |
| MNDR | hsa-miR-760 | Amyotrophic lateral sclerosis | MNDR-E-MI-68916 |
| MNDR | hsa-miR-760 | Osteosarcoma | MNDR-E-MI-68917 |
| MNDR | hsa-miR-760 | Breast carcinoma | MNDR-E-MI-68918 |
| MNDR | hsa-miR-760 | Lung squamous cell carcinoma | MNDR-E-MI-68919 |
| MNDR | hsa-mir-760 | Non-small cell lung cancer | MNDR-E-MI-68920 |
| MNDR | hsa-miR-760 | Lung adenocarcinoma | MNDR-E-MI-68921 |
| MNDR | hsa-miR-760 | Thyroid carcinoma | MNDR-E-MI-68922 |
| MNDR | hsa-mir-760 | Carcinoma renal cell | MNDR-E-MI-68923 |
| MNDR | hsa-miR-760 | Kidney renal clear cell carcinoma | MNDR-E-MI-68924 |
| MNDR | hsa-miR-760 | Kidney renal papillary cell carcinoma | MNDR-E-MI-68925 |
| MNDR | hsa-miR-760 | Renal clear cell carcinoma | MNDR-E-MI-68926 |
| MNDR | hsa-miR-760 | Biliary tract cancer | MNDR-E-MI-68927 |
| MNDR | hsa-miR-760 | Esophageal cancer | MNDR-E-MI-68928 |
| MNDR | hsa-miR-760 | Lung small cell carcinoma | MNDR-E-MI-68929 |
| MNDR | hsa-miR-760 | Breast invasive carcinoma | MNDR-E-MI-68930 |
| MNDR | hsa-miR-760 | Progressive supranuclear palsy | MNDR-E-MI-68931 |
| MNDR | hsa-miR-760 | Hepatocellular carcinoma | MNDR-E-MI-68932 |
| MNDR | hsa-mir-760 | Hepatocellular carcinoma | MNDR-E-MI-68933 |
| MNDR | hsa-miR-760 | Retinoblastoma | MNDR-E-MI-68934 |
| MNDR | hsa-miR-760 | Hodgkin lymphoma | MNDR-E-MI-68935 |
| MNDR | hsa-miR-760 | Skin cutaneous melanoma | MNDR-E-MI-68936 |
| MNDR | hsa-miR-760 | Skin melanoma | MNDR-E-MI-68937 |
| MNDR | hsa-miR-760 | Colorectal cancer | MNDR-E-MI-68938 |
| MNDR | hsa-mir-760 | Colorectal cancer | MNDR-E-MI-68939 |
| MNDR | hsa-miR-760 | Nasopharynx carcinoma | MNDR-E-MI-68940 |
| MNDR | hsa-miR-760 | Nasopharyngeal cancer | MNDR-E-MI-68941 |
| MNDR | hsa-miR-760 | Breast cancer her3+ negative | MNDR-E-MI-68942 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CSNK2A1 | Homo sapiens | RR00372940 |
TOP